Proprietary AI analyst is now available
- Public Comps
- Syno Capital Group
Syno Capital Group Valuation Multiples
Discover Syno Capital Group's revenue and EBITDA valuation multiples and investment history, alongside public comparables like SoftBank Group, BlackRock, Blackstone, Investor AB and more.
Syno Capital Group Overview
About Syno Capital Group
Syno Capital Group Inc is a diversified enterprise focused on long-term value investment, digital commerce, and financial technology. Its core business segments are: i) Smart Value Investment Fund: As the core profit engine of the company, it focuses on long-term investment in the fields of consumption, energy and technology, and uses AI technology for investment research and risk management. ii) Digital commerce: through the intelligent e-commerce ecosystem, enhance user experience and business efficiency, and promote digital transformation. iii) Financial technology: upgrade the core competence of financial technology tools and provide financial services and solutions.
Founded
2025
HQ

Employees
N/A
Website
Sectors
Financials (FY)
Market Cap
-
Valuation Multiples
Start free trialSyno Capital Group Stock Performance
Syno Capital Group has current market cap of -.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSyno Capital Group Valuation Multiples
Syno Capital Group Financial Valuation Multiples
As of June 6, 2026, Syno Capital Group has market cap of -.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Syno Capital Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Syno Capital Group Competitors
Syno Capital Group competitors include SoftBank Group, BlackRock, Blackstone, Investor AB, Brookfield, KKR, Brookfield Asset Management, Apollo Global Management, EQT and Ares Management.
Most Syno Capital Group public comparables operate across PE & VC.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 8.3x | 7.6x | 19.1x | 7.9x | |||
| 6.6x | 6.2x | 16.3x | 14.7x | |||
| 12.2x | 11.5x | 20.7x | 19.5x | |||
| 5.9x | 19.1x | 8.4x | 9.4x | |||
| 4.6x | 44.0x | 11.0x | 51.4x | |||
| 0.6x | 1.2x | 1.1x | 1.9x | |||
| 14.1x | 13.6x | 24.0x | 25.1x | |||
| (5.1x) | (5.8x) | (19.3x) | (24.5x) | |||
This data is available for Pro users. Sign up to see all Syno Capital Group competitors and their valuation data. Start Free Trial | ||||||
Investments by Syno Capital Group
Syno Capital Group has invested in 4 companies to date.
Latest investment by Syno Capital Group was on February 1st 2019. Syno Capital Group invested in Applied Therapeutics in their $25M Series B round (EV/Revenue multiple available to Pro users).
Latest Investments by Syno Capital Group
| Description | - | - | ORIG3N is a Boston-headquartered biotechnology company founded in 2014 that engineers consumer genomics services and gene therapies for rare inherited diseases. It targets conditions in cardiology, hepatology, and neurology using proprietary platforms like LiFT for large-scale DNA printing. ORIG3N offers direct-to-consumer genetic testing kits through partnerships with retailers and develops CRISPR-based treatments for disorders such as familial hypercholesterolemia. The firm operates labs in Woburn, Massachusetts, and collaborates with academic institutions to advance personalized medicine applications. | - | |
| HQ Country | - | - | - | ||
| HQ City | - | - | Boston, MA | - | |
| Deal Date | 1 Feb 2019 | 5 Sep 2018 | 27 Jun 2017 | 8 Feb 2017 | |
| Round | Series B | Series D | Undisclosed stage | Series A | |
| Raised | $25M | $34M | $20M | $6M | |
| Investors | Alexandria Venture Investments; E Squared Capital Management; ETP Fund; Franklin Berger; Syno Capital Group; THE CATALYTIC IMPACT FOUNDATION (CIF) | Cormorant Asset Management; Fletcher Spaght; Hatteras Venture Partners; Johnson & Johnson Innovation; Mountain Group Capital; New Enterprise Associates; Rock Springs Capital; Syno Capital Group; AstraZeneca | 180 Degree Capital; DEFTA Partners; Hatteras Venture Partners; DAOL Investment; Labcorp; MGC Venture Partners; Spectrum Health Ventures; Syno Capital Group | Alexandria Venture Investments; E Squared Capital Management; ETP Fund; Franklin Berger; Syno Capital Group | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Syno Capital Group investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Syno Capital Group
| When was Syno Capital Group founded? | Syno Capital Group was founded in 2025. |
| Where is Syno Capital Group headquartered? | Syno Capital Group is headquartered in United States. |
| Is Syno Capital Group publicly listed? | Yes, Syno Capital Group is a public company listed on Nasdaq. |
| What is the stock symbol of Syno Capital Group? | Syno Capital Group trades under SYNO ticker. |
| When did Syno Capital Group go public? | Syno Capital Group went public in 2050. |
| Who are competitors of Syno Capital Group? | Syno Capital Group main competitors include SoftBank Group, BlackRock, Blackstone, Investor AB, Brookfield, KKR, Brookfield Asset Management, Apollo Global Management, EQT, Ares Management. |
| Is Syno Capital Group profitable? | No, Syno Capital Group is not profitable. |
| How many companies Syno Capital Group has acquired to date? | Syno Capital Group hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Syno Capital Group has invested to date? | As of June 2026, Syno Capital Group has invested in 4 companies. |
| What was the last Syno Capital Group investment? | On 1st February 2019 Syno Capital Group invested in Applied Therapeutics, participating in a $25M Series B round, alongside Alexandria Venture Investments, E Squared Capital Management, ETP Fund, Franklin Berger, and THE CATALYTIC IMPACT FOUNDATION (CIF). |
| In what companies Syno Capital Group invested in? | Syno Capital Group invested in Honor, LungLife AI, Applied Therapeutics, and ORIG3N. |
See public comps similar to Syno Capital Group
Lists including Syno Capital Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
